Post hoc pairwise comparison concerning the EF% between regimens (Tukey HSD) in the four groups
| (I) Regimen | (J) Regimen | Mean difference (I—J) | Std. error | Sig. | 95% confidence interval | |
|---|---|---|---|---|---|---|
| Lower bound | Upper bound | |||||
| Conventional | ARNi regimen | 3.864 | 2.160 | 0.284 | −1.77 | 9.50 |
| SGLT2i regimen | 4.121 | 1.932 | 0.149 | −0.92 | 9.16 | |
| Quadruple GDMT | 5.267* | 1.980 | 0.044 | 0.10 | 10.43 | |
| (I) Regimen | (J) Regimen | Mean difference (I—J) | Std. error | Sig. | 95% confidence interval | |
|---|---|---|---|---|---|---|
| Lower bound | Upper bound | |||||
| Conventional | 3.864 | 2.160 | 0.284 | −1.77 | 9.50 | |
| 4.121 | 1.932 | 0.149 | −0.92 | 9.16 | ||
| 5.267* | 1.980 | 0.044 | 0.10 | 10.43 | ||
Note(s): ARNi: Angiotensin Receptor-Neprilysin Inhibitor; GDMT: guideline-directed medical therapy; SGLT-2i: sodium-glucose cotransporter 2 inhibitors